May 14, 2021
6:5
For every 5 shares held, investors received 6. The price per share adjusted from $20.58 to $17.15.
The split itself did not change the total investment value.
Anhui Anke Biotechnology (Group) Co., Ltd. Class A (SZSE:300009) operates in the Pharmaceuticals: major industry.
Anhui Anke Biotechnology (Group) Co., Ltd. Class A company overviewAnhui Anke Biotechnology (Group) Co., Ltd. Class A's most recent stock split was on May 14, 2021. It was a 6-for-5 forward split, so shareholders received 6 shares for every 5 they held.
Anhui Anke Biotechnology (Group) Co., Ltd. Class A (SZSE:300009) has split its stock 10 times: a 9-for-5 split on May 12, 2010, a 5-for-4 split on May 6, 2011, a 1133-for-911 split on June 13, 2013, a 6-for-5 split on June 13, 2014, a 13-for-10 split on April 17, 2015, a 13-for-10 split on April 15, 2016, a 13-for-10 split on May 18, 2017, a 7-for-5 split on May 4, 2018, a 13-for-10 split on May 22, 2020, and a 6-for-5 split on May 14, 2021.
Anhui Anke Biotechnology (Group) Co., Ltd. Class A has split its stock 10 times. This history records 10 forward splits between May 12, 2010 and May 14, 2021.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Anhui Anke Biotechnology (Group) Co., Ltd. Class A's 6-for-5 split on May 14, 2021, every 5 shares became 6 shares.
Anhui Anke Biotechnology (Group) Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on May 14, 2021, 5 years ago. Companies announce splits in advance, and any new SZSE:300009 split will appear on this page.
Already premium?